Cleared Traditional

K180388 - Transcend 365 miniCPAP System

K180388 is the FDA 510(k) clearance for Transcend 365 miniCPAP System by Somnetics International, Inc.. It is a Class 2 Anesthesiology device (product code BZD) cleared through the Traditional 510(k) pathway after a 290-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
290d
Days
Class 2
Risk

K180388 is an FDA 510(k) clearance for the Transcend 365 miniCPAP System. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.

Submitted by Somnetics International, Inc. (New Brighton, US). The FDA issued a Cleared decision on November 30, 2018 after a review of 290 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Somnetics International, Inc. devices

Submission Details

510(k) Number K180388 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2018
Decision Date November 30, 2018
Days to Decision 290 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
150d slower than avg
Panel avg: 140d · This submission: 290d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BZD Ventilator, Non-continuous (respirator)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Bluebird Consulting, LLC
Melinda Swanson

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - BZD Ventilator, Non-continuous (respirator)

All 246
Devices cleared under the same product code (BZD) and FDA review panel - the closest regulatory comparables to K180388.
WiZARD 310/320 Series CPAP Mask
K182394 · Apex Medical Corp. · May 2019
Moore Park Mask
K183512 · Resmed, Ltd. · May 2019
Care Orchestrator
K181053 · Respironics, Inc. · Jan 2019
F&P SleepStyle
K173193 · Fisher &Paykel Healthcare , Ltd. · Aug 2018
Scone Mask
K180497 · Resmed, Ltd. · Jun 2018
Bleep DreamPort
K172335 · Snapcpap · Mar 2018